Lemon Tree Hotels Limited (BOM:541233)

Inozyme Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	806.73	336.44	236.82	542.86	1,275
Short-Term Investments	-	385.74	203.31	37.97	-	136.85
Trading Asset Securities	-	-	80.91	9.97	59.47	9.11
Cash & Short-Term Investments	1,192	1,192	620.67	284.76	602.33	1,421
Cash Growth	92.85%	92.13%	117.96%	-52.72%	-57.60%	189.18%
Accounts Receivable	-	786.16	716.18	562.71	304.15	317.67
Other Receivables	-	-	53.98	23.48	5.1	14.04
Receivables	-	786.16	770.16	586.19	309.25	331.7
Inventory	-	138.37	138.36	105.22	81.23	72.25
Prepaid Expenses	-	-	129.68	101.37	75.42	78.42
Other Current Assets	-	817.33	394.53	282.82	241.57	399.41
Total Current Assets	-	2,934	2,053	1,360	1,310	2,302
Property, Plant & Equipment	-	34,748	35,315	33,250	32,358	33,209
Long-Term Investments	-	60.18	52.4	45.39	36.71	46.31
Goodwill	-	950.84	950.84	950.84	950.84	950.84
Other Intangible Assets	-	448.97	399.98	194.31	169.77	195.27
Long-Term Deferred Tax Assets	-	209.37	358.29	364.73	460.76	403.65
Other Long-Term Assets	-	1,464	1,198	1,155	1,060	1,069
Total Assets	-	40,818	40,330	37,323	36,350	38,185
Accounts Payable	-	616.08	858.84	667.97	585.11	774.04
Accrued Expenses	-	-	232.57	249.19	302.27	107.18
Short-Term Debt	-	-	35.76	576.56	362.02	634.65
Current Portion of Long-Term Debt	-	2,052	2,099	1,708	1,097	1,122
Current Portion of Leases	-	59.53	43.84	58.35	45.81	71.23
Current Unearned Revenue	-	-	3.54	3.21	2.14	1.72
Other Current Liabilities	-	713.36	317.57	438.05	138.73	252.66
Total Current Liabilities	-	3,441	3,591	3,701	2,533	2,963
Long-Term Debt	-	14,934	16,767	15,174	15,535	15,135
Long-Term Leases	-	4,431	4,423	4,253	4,247	4,671
Long-Term Deferred Tax Liabilities	-	71.68	52.78	35.82	20.05	36.96
Other Long-Term Liabilities	-	9.77	-	-	-	-
Total Liabilities	-	22,922	24,866	23,189	22,362	22,836
Common Stock	-	7,918	7,918	7,916	7,908	7,904
Additional Paid-In Capital	-	-	1,057	1,054	1,045	1,041
Retained Earnings	-	-	-893.89	-2,379	-3,524	-2,648
Comprehensive Income & Other	-	3,717	1,587	1,946	2,884	2,879
Total Common Equity	11,635	11,635	9,669	8,537	8,312	9,176
Minority Interest	-	6,261	5,795	5,597	5,676	6,174
Shareholders' Equity	17,896	17,896	15,464	14,134	13,989	15,350
Total Liabilities & Equity	-	40,818	40,330	37,323	36,350	38,185
Total Debt	21,476	21,476	23,369	21,770	21,287	21,634
Net Cash (Debt)	-20,284	-20,284	-22,748	-21,485	-20,685	-20,213
Net Cash Per Share	-25.54	-25.59	-28.73	-27.15	-26.16	-25.59
Filing Date Shares Outstanding	798.57	791.85	791.85	791.61	790.81	790.42
Total Common Shares Outstanding	798.57	791.85	791.85	791.61	790.81	790.42
Working Capital	-	-506.58	-1,538	-2,341	-1,223	-661.1
Book Value Per Share	14.69	14.69	12.21	10.78	10.51	11.61
Tangible Book Value	10,235	10,235	8,318	7,392	7,192	8,030
Tangible Book Value Per Share	12.93	12.93	10.50	9.34	9.09	10.16
Land	-	-	5,013	5,013	5,013	5,013
Buildings	-	-	24,162	19,114	19,110	18,993
Machinery	-	-	7,217	5,046	4,941	4,884
Construction In Progress	-	-	248.42	4,691	2,946	2,418

Source: S&P Global Market Intelligence. Standard template. Financial Sources.